Delivery bottlenecks for important medicines: “Situation very tense”. For 85 percent of urgently needed medicines, the pharmaceutical trade can meet the statutory requirement of two weeks.
With a total of 104,000 drugs approved in Germany, this is a rate of less than 0.5 percent. For many medicines, a single manufacturer accounts for 50 percent of the supply. There is only one large producer on the market for the breast cancer drug Tamoxifen. The pharmaceutical industry accuses: ‘Politicians are just putting small plasters on the problems’